TNK2 and prostate carcinoma: Both activated ACK1 (pY284-ACK1 or pACK1) and AR levels increases as prostate cancer progresses from the benign prostatic hyperplasia (BPH) to the late stages of prostate cancer including the metastatic stage28,59.